0001437749-16-043049.txt : 20161207 0001437749-16-043049.hdr.sgml : 20161207 20161207171121 ACCESSION NUMBER: 0001437749-16-043049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161205 FILED AS OF DATE: 20161207 DATE AS OF CHANGE: 20161207 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wrighton-Smith Peter CENTRAL INDEX KEY: 0001592286 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 162039841 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL PLC STREET 2: 94C INNOVATION DRIVE CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2016-12-05 0001586049 Oxford Immunotec Global PLC OXFD 0001592286 Wrighton-Smith Peter C/O OXFORD IMMUNOTEC GLOBAL PLC 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 1 Chief Executive Officer Ordinary Shares 2016-12-05 4 M 0 1140 0.81 A 444454 D Ordinary Shares 2016-12-05 4 S 0 1140 15 D 443314 D Stock Option (Right to Buy) 0.81 2016-12-05 4 M 0 1140 0 D 2020-02-17 Ordinary Shares 1140 108490 D The original exercise price of these options was priced in GBP at GBP0.51 and converted to US$ at an exchange rate of US$1.58823=1GBP. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 10, 2015, as amended. Exercise from an option granted February 28, 2013, which became fully vested on April 1, 2014. /s/ Elizabeth M. Keiley, as Attorney-in-Fact 2016-12-07